DossierENTITY

oncology medicines

Coverage of oncology medicines in the Nexus archive.

Earliest in view: May 29 · 03:10 UTCMost recent: May 29 · 03:10 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSMay 29 · 03:10 UTCCNBC TOP
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Innovent Biologics' shares increased by 10% following a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines, with the pact valued up to $10.5 billion.